ATRX and glioblastoma: ATRX deficiency has been shown to accelerate GBM growth and reduce survival, linking ATRX loss to DNA repair deficiencies, particularly impaired nonhomologous end joining.108 These findings suggest that ATRX-deficient GBMs are vulnerable to therapies targeting DNA damage repair pathways.